FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304959474> ?p ?o ?g. }

• W4304959474 endingPage "8" @default.
• W4304959474 startingPage "1" @default.
• W4304959474 abstract "Greece was recently reclassified from low- to medium-risk country in terms of cardiovascular disease, with 27% of cardiovascular deaths attributed to hypercholesterolemia. EMENO nationwide survey (2013-2016) assessed the epidemiology of dyslipidemia in the general population in Greece.A random sample of adults was drawn by multistage stratified random sampling based on 2011 census. Standardized questionnaires and blood tests for total cholesterol (TC), low-density (LDL-C), and high-density lipoprotein cholesterol (HDL-C), and triglycerides were used. Hypercholesterolemia was defined as TC ≥ 240/200 mg/dL and/or the use of lipid-lowering drugs, hyper-LDL-cholesterolemia as LDL-C ≥160/130/100 mg/dL and/or the use of drugs, hypo-HDL-cholesterolemia as HDL-C <40 mg/dL, and hypertriglyceridemia as triglycerides ≥150 mg/dL. Weighted analysis was applied to adjust for study design, age/sex distribution discrepancies between sample and population and nonresponse.Of 6,006 individuals recruited, 4,298 were analyzed (mean [SD] age 49.2 [18.5] years, men 48.5%, BMI 28.2 [5.7] kg/m2). Mean TC, LDL-C, HDL-C, and TG were 193.9 [44.4], 118.5 [37.6], 49.1 [14.9], and 130.8 [94.4] mg/dL, respectively. The prevalence of hypercholesterolemia was 27.6/52.4% for thresholds ≥240/200 mg/dL, and of hyper-LDL-cholesterolemia was 26.3/46.7/74% for thresholds ≥160/130/100 mg/dL, with no differences between sexes. The prevalence of hypo-HDL-cholesterolemia was 27.5% (men/women 38.1/17.5%, p < 0.001) and of hypertriglyceridemia was 27.8% (men/women 32.6/23.4%, p < 0.001). Lipid-lowering drugs were used by 14.1% of the participants (men/women 12.6/15.6%, p < 0.001).More than 50% of adults in Greece have some type of dyslipidemia (mainly TC ≥ 200 mg/dL) and 14% are treated. Nationwide programmes are needed to manage dyslipidemia and halt the increasing rate of cardiovascular disease in Greece." @default.
• W4304959474 created "2022-10-14" @default.
• W4304959474 creator A5008628863 @default.
• W4304959474 creator A5024619850 @default.
• W4304959474 creator A5024648271 @default.
• W4304959474 creator A5025992165 @default.
• W4304959474 creator A5032584545 @default.
• W4304959474 creator A5033140531 @default.
• W4304959474 creator A5033646221 @default.
• W4304959474 creator A5035360425 @default.
• W4304959474 creator A5036358559 @default.
• W4304959474 creator A5037986150 @default.
• W4304959474 creator A5043700761 @default.
• W4304959474 creator A5054058404 @default.
• W4304959474 creator A5068103159 @default.
• W4304959474 creator A5068721640 @default.
• W4304959474 creator A5068835724 @default.
• W4304959474 creator A5069034692 @default.
• W4304959474 creator A5085936558 @default.
• W4304959474 date "2023-01-01" @default.
• W4304959474 modified "2023-09-26" @default.
• W4304959474 title "Twenty-first century epidemiology of dyslipidemia in Greece: EMENO national epidemiological study" @default.
• W4304959474 cites W1971263893 @default.
• W4304959474 cites W1972661406 @default.
• W4304959474 cites W2047599024 @default.
• W4304959474 cites W2070652849 @default.
• W4304959474 cites W2077876793 @default.
• W4304959474 cites W2111099202 @default.
• W4304959474 cites W2127427274 @default.
• W4304959474 cites W2143047519 @default.
• W4304959474 cites W2305581719 @default.
• W4304959474 cites W2331439827 @default.
• W4304959474 cites W2338134605 @default.
• W4304959474 cites W2580792129 @default.
• W4304959474 cites W2891365939 @default.
• W4304959474 cites W2898072415 @default.
• W4304959474 cites W2965531610 @default.
• W4304959474 cites W3104883992 @default.
• W4304959474 cites W3112697580 @default.
• W4304959474 cites W3120916025 @default.
• W4304959474 cites W3130171947 @default.
• W4304959474 cites W3142840603 @default.
• W4304959474 cites W3183857127 @default.
• W4304959474 cites W3197233987 @default.
• W4304959474 cites W3197909252 @default.
• W4304959474 cites W3209738229 @default.
• W4304959474 cites W4230870013 @default.
• W4304959474 cites W2005963419 @default.
• W4304959474 doi "https://doi.org/10.1016/j.hjc.2022.10.002" @default.
• W4304959474 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36243397" @default.
• W4304959474 hasPublicationYear "2023" @default.
• W4304959474 type Work @default.
• W4304959474 citedByCount "4" @default.
• W4304959474 countsByYear W43049594742023 @default.
• W4304959474 crossrefType "journal-article" @default.
• W4304959474 hasAuthorship W4304959474A5008628863 @default.
• W4304959474 hasAuthorship W4304959474A5024619850 @default.
• W4304959474 hasAuthorship W4304959474A5024648271 @default.
• W4304959474 hasAuthorship W4304959474A5025992165 @default.
• W4304959474 hasAuthorship W4304959474A5032584545 @default.
• W4304959474 hasAuthorship W4304959474A5033140531 @default.
• W4304959474 hasAuthorship W4304959474A5033646221 @default.
• W4304959474 hasAuthorship W4304959474A5035360425 @default.
• W4304959474 hasAuthorship W4304959474A5036358559 @default.
• W4304959474 hasAuthorship W4304959474A5037986150 @default.
• W4304959474 hasAuthorship W4304959474A5043700761 @default.
• W4304959474 hasAuthorship W4304959474A5054058404 @default.
• W4304959474 hasAuthorship W4304959474A5068103159 @default.
• W4304959474 hasAuthorship W4304959474A5068721640 @default.
• W4304959474 hasAuthorship W4304959474A5068835724 @default.
• W4304959474 hasAuthorship W4304959474A5069034692 @default.
• W4304959474 hasAuthorship W4304959474A5085936558 @default.
• W4304959474 hasBestOaLocation W43049594741 @default.
• W4304959474 hasConcept C107130276 @default.
• W4304959474 hasConcept C126322002 @default.
• W4304959474 hasConcept C2776919658 @default.
• W4304959474 hasConcept C2778096610 @default.
• W4304959474 hasConcept C2778163477 @default.
• W4304959474 hasConcept C2778913445 @default.
• W4304959474 hasConcept C2779120738 @default.
• W4304959474 hasConcept C2779134260 @default.
• W4304959474 hasConcept C2908647359 @default.
• W4304959474 hasConcept C71924100 @default.
• W4304959474 hasConcept C99454951 @default.
• W4304959474 hasConceptScore W4304959474C107130276 @default.
• W4304959474 hasConceptScore W4304959474C126322002 @default.
• W4304959474 hasConceptScore W4304959474C2776919658 @default.
• W4304959474 hasConceptScore W4304959474C2778096610 @default.
• W4304959474 hasConceptScore W4304959474C2778163477 @default.
• W4304959474 hasConceptScore W4304959474C2778913445 @default.
• W4304959474 hasConceptScore W4304959474C2779120738 @default.
• W4304959474 hasConceptScore W4304959474C2779134260 @default.
• W4304959474 hasConceptScore W4304959474C2908647359 @default.
• W4304959474 hasConceptScore W4304959474C71924100 @default.
• W4304959474 hasConceptScore W4304959474C99454951 @default.
• W4304959474 hasLocation W43049594741 @default.
• W4304959474 hasLocation W43049594742 @default.
• W4304959474 hasOpenAccess W4304959474 @default.

• next